Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             37 results found
no title author magazine year volume issue page(s) type
1 A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers Leroux-Roels, Geert
2004
22 23-24 p. 3080-3086
7 p.
article
2 Active immunization against murine TNFα peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection Capini, C.J
2004
22 23-24 p. 3144-3153
10 p.
article
3 Adolescent and adult pertussis vaccination: computer simulations of five new strategies Van Rie, Annelies
2004
22 23-24 p. 3154-3165
12 p.
article
4 Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type Rimaniol, Anne-Cécile
2004
22 23-24 p. 3127-3135
9 p.
article
5 A murine model for the study of immune memory in response to pneumococcal conjugate vaccination Moreno, R.L
2004
22 23-24 p. 3069-3079
11 p.
article
6 An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity Ophorst, Olga J.A.E
2004
22 23-24 p. 3035-3044
10 p.
article
7 A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine Ault, Kevin A
2004
22 23-24 p. 3004-3007
4 p.
article
8 A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus Poirriez, Jean
2004
22 23-24 p. 3166-3168
3 p.
article
9 Author Index for Volume 21 (2003) 2004
22 23-24 p. XXIV-XXXIX
nvt p.
article
10 CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection Bogers, W.M.J.M.
2004
22 23-24 p. 2974-2984
11 p.
article
11 Characteristics of Vibrio cholerae proteinases: potential, candidate vaccine antigens Stewart-Tull, D.E.S.
2004
22 23-24 p. 3026-3034
9 p.
article
12 Editorial Board/Aims and Scope 2004
22 23-24 p. IFC-
1 p.
article
13 Ethical principles for collective immunisation programmes Verweij, Marcel
2004
22 23-24 p. 3122-3126
5 p.
article
14 Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant Barouch, Dan H
2004
22 23-24 p. 3092-3097
6 p.
article
15 Full-length HIV-1 Tat protein necessary for a vaccine Opi, Sandrine
2004
22 23-24 p. 3105-3111
7 p.
article
16 Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza Lee, Chang-Won
2004
22 23-24 p. 3175-3181
7 p.
article
17 Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen Tewary, Poonam
2004
22 23-24 p. 3053-3060
8 p.
article
18 Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali Lyke, Kirsten E
2004
22 23-24 p. 3169-3174
6 p.
article
19 Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing Noble, Simon
2004
22 23-24 p. 3018-3025
8 p.
article
20 Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae Sabirov, Albert
2004
22 23-24 p. 3112-3121
10 p.
article
21 Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2 Kwant, Amanda
2004
22 23-24 p. 3098-3104
7 p.
article
22 Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants Gaofu, Qi
2004
22 23-24 p. 3187-3194
8 p.
article
23 Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau Aaby, Peter
2004
22 23-24 p. 3014-3017
4 p.
article
24 PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children Vermont, C.L
2004
22 23-24 p. 3008-3013
6 p.
article
25 Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28—evaluation of homologous and heterologous antigen-delivery prime-boost strategy Kongkasuriyachai, Darin
2004
22 23-24 p. 3205-3213
9 p.
article
26 Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys Fan, Jiang
2004
22 23-24 p. 2993-3003
11 p.
article
27 Prediction of CTL epitopes using QM, SVM and ANN techniques Bhasin, Manoj
2004
22 23-24 p. 3195-3204
10 p.
article
28 Reactions after pneumococcal vaccine alone or in combination with influenza vaccine Sočan, Maja
2004
22 23-24 p. 3087-3091
5 p.
article
29 Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine Isaka, Masanori
2004
22 23-24 p. 3061-3068
8 p.
article
30 Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine Cooper, C.L
2004
22 23-24 p. 3136-3143
8 p.
article
31 Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults Slobod, Karen S
2004
22 23-24 p. 3182-3186
5 p.
article
32 Subject Index for Volume 21 (2003) 2004
22 23-24 p. I-XXIII
nvt p.
article
33 Systematic review of the effects of pertussis vaccines in children Simondon, François
2004
22 23-24 p. 2965-
1 p.
article
34 The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials Conaty, Stephen
2004
22 23-24 p. 3214-3224
11 p.
article
35 Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects Fernandez-Cruz, E
2004
22 23-24 p. 2966-2973
8 p.
article
36 Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics Tacken, M.A.J.B
2004
22 23-24 p. 2985-2992
8 p.
article
37 Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation Mesa, Circe
2004
22 23-24 p. 3045-3052
8 p.
article
                             37 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands